Published in Semin Neurol on February 01, 2007
Gait disturbances in old age: classification, diagnosis, and treatment from a neurological perspective. Dtsch Arztebl Int (2010) 1.75
The differential diagnosis and treatment of normal-pressure hydrocephalus. Dtsch Arztebl Int (2012) 0.97
A Spiking Working Memory Model Based on Hebbian Short-Term Potentiation. J Neurosci (2017) 0.75
MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS (2015) 0.75
Memory loss with enlarged brain ventricles. BMJ Case Rep (2009) 0.75
Neurosyphilis With Normal Pressure Hydrocephalus and Dementia Paralytica: Serial Clinical, Laboratory and Radiological Correlations in the 21st Century. Neurol Int (2016) 0.75
Reversible parkinsonism due to a large intracranial tumour. BMJ Case Rep (2012) 0.75
Cognitive functions after spinal tap in patients with normal pressure hydrocephalus. J Neurol (2014) 0.75
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med (2004) 2.82
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol (2007) 2.30
Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH. Neurology (2014) 2.08
Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease. Alzheimer Dis Assoc Disord (2003) 1.79
Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals. Exp Gerontol (2002) 1.68
The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery (2005) 1.52
Natural human antibodies to amyloid beta peptide. Autoimmun Rev (2008) 1.20
Surgical management of idiopathic normal-pressure hydrocephalus. Neurosurgery (2005) 1.15
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int (2003) 1.13
Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients. Neurosurgery (2005) 1.12
Increased diffusion in the brain of professional boxers: a preclinical sign of traumatic brain injury? AJNR Am J Neuroradiol (2003) 1.01
Development of guidelines for idiopathic normal-pressure hydrocephalus: introduction. Neurosurgery (2005) 0.99
Proteomic analysis of cerebrospinal fluid changes related to postmortem interval. Clin Chem (2006) 0.97
Measurement of anti-beta amyloid antibodies in human blood. J Neuroimmunol (2010) 0.97
Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease. Electrophoresis (2002) 0.91
The Network Modification (NeMo) Tool: elucidating the effect of white matter integrity changes on cortical and subcortical structural connectivity. Brain Connect (2013) 0.89
Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro. Mol Med (2002) 0.83
Exploring the brain's structural connectome: A quantitative stroke lesion-dysfunction mapping study. Hum Brain Mapp (2015) 0.82
Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapy. Alzheimers Dement (2008) 0.81
Longitudinal effects of intravenous immunoglobulin on Alzheimer's cerebrospinal fluid proteome. Electrophoresis (2014) 0.75
Cholinergic components of frontal lobe function and dysfunction. Handb Clin Neurol (2008) 0.75
Pesticide exposure and dementia. J Am Geriatr Soc (2004) 0.75